{"date":"2026-03-04","count":105,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4728-2026-03-04-2306-wu2q5q","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"23:06:15","subject":"公告本公司114年度財務報告董事會召開日期。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-04 23:06，「公告本公司114年度財務報告董事會召開日期。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-03-04-2047-1atzuj8","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"20:47:47","subject":"衛福部核准佛教慈濟醫療財團法人台中慈濟醫院與本公司合作之「自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損」細胞治療技術施行計畫","clause":"第53款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-03-04 20:47，「衛福部核准佛教慈濟醫療財團法人台中慈濟醫院與本公司合作之「自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損」細胞治療技術施」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-04-2042-vxxmjv","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"20:42:22","subject":"公告華上生醫自主開發具免疫調控活性的多重激酉每抑制劑抗癌新藥GNTbm-TKI (代號: Cbo-23)，經審查取得台灣發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-04 20:42，「公告華上生醫自主開發具免疫調控活性的多重激酉每抑制劑抗癌新藥GNTbm-TKI (代號: Cbo-23)，經審查取得台灣」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-03-04-2023-1n2p0g5","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"20:23:55","subject":"公告本公司114年度盈餘分配現金股利之除息基準日相關事宜","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-03-04 20:23，「公告本公司114年度盈餘分配現金股利之除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-03-04-1949-11wjw0o","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"19:49:08","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-03-04 19:49，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-03-04-1909-172uzvr","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"19:09:48","subject":"董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-03-04 19:09，「董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-04-1905-158ihrk","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"19:05:33","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-04 19:05，「公告本公司114年度財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1855-b5qkd","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:55:13","subject":"公告本公司董事會通過增資100%子公司育世博生物科技股份有限公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:55，「公告本公司董事會通過增資100%子公司育世博生物科技股份有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1852-1uop06l","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:52:41","subject":"代重要子公司育世博生物科技(股)公司公告決議辦理現金增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:52，「代重要子公司育世博生物科技(股)公司公告決議辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1851-bwopfv","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:51:50","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:51，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1851-z6skxx","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:51:12","subject":"公司114年底累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:51，「公司114年底累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1848-5j9yh6","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:48:32","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:48，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1844-1k9t4y6","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:44:42","subject":"公告本公司董事會決議委任公司治理主管","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:44，「公告本公司董事會決議委任公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-03-04-1842-f66hij","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"18:42:54","subject":"公告114年第四季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-03-04 18:42，「公告114年第四季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1842-1sscpnj","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:42:03","subject":"公告本公司董事會決議註銷限制員工權利新股減資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:42，「公告本公司董事會決議註銷限制員工權利新股減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-03-04-1839-11b1948","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:39:43","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-03-04 18:39，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-03-04-1831-up0ud4","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:31:53","subject":"本公司口服胜月太藥品(ANY004)獲得澳洲人體研究倫理委員會（HREC）核准進行臨床一期試驗","clause":"第8款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-03-04 18:31，「本公司口服胜月太藥品(ANY004)獲得澳洲人體研究倫理委員會（HREC）核准進行臨床一期試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-03-04-1830-11b1948","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:30:12","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-03-04 18:30，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-03-04-1826-118bgda","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"18:26:08","subject":"公告本公司115年股東臨時會決議解除董事競業禁止案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-03-04 18:26，「公告本公司115年股東臨時會決議解除董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-03-04-1825-9o41gz","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"18:25:40","subject":"公告本公司115年股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-03-04 18:25，「公告本公司115年股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-03-04-1824-5y8knn","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:24:57","subject":"本公司向關係人取得不動產使用權資產","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-03-04 18:24，「本公司向關係人取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-03-04-1814-xumkgb","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:14:50","subject":"本公司董事會決議召開115年股東常會公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-03-04 18:14，「本公司董事會決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-03-04-1813-1ufkupd","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"18:13:51","subject":"公告本公司現金增資催繳期間屆滿暨股票發放事宜","clause":"第51款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-03-04 18:13，「公告本公司現金增資催繳期間屆滿暨股票發放事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-03-04-1812-drgvb6","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:12:56","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-03-04 18:12，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-03-04-1811-1hcai8l","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:11:18","subject":"公告本公司董事會決議114年度不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-03-04 18:11，「公告本公司董事會決議114年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-03-04-1809-1fgx4fh","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"18:09:45","subject":"公告本公司董事會決議通過114年度財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-03-04 18:09，「公告本公司董事會決議通過114年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-03-04-1804-14q9n0v","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"18:04:53","subject":"公告本公司副總經理退休","clause":"第8款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-03-04 18:04，「公告本公司副總經理退休」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-03-04-1759-5xjbf0","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"17:59:25","subject":"公告本公司董事會決議召開115年股東會相關事宜","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-03-04 17:59，「公告本公司董事會決議召開115年股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-03-04-1752-zup54x","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"17:52:44","subject":"公告本公司改派法人董事案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-03-04 17:52，「公告本公司改派法人董事案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-03-04-1749-1vdwe7l","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"17:49:35","subject":"公告董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第9款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-03-04 17:49，「公告董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-03-04-1748-1dzzmaz","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"17:48:46","subject":"本公司114年度合併財務報告已提報董事會","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-03-04 17:48，「本公司114年度合併財務報告已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-03-04-1748-bwopfv","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"17:48:36","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-03-04 17:48，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-03-04-1747-1b89la1","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"17:47:59","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-03-04 17:47，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-03-04-1746-oz6nrh","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:46:16","subject":"公告本公司董事會決議召開本公司115年股東常會","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-03-04 17:46，「公告本公司董事會決議召開本公司115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-03-04-1743-13bqai2","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"17:43:20","subject":"本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-03-04 17:43，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-03-04-1741-11wjw0o","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:41:51","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-03-04 17:41，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-03-04-1741-5j9yh6","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:41:32","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-03-04 17:41，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-03-04-1735-11wjw0o","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"17:35:44","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-03-04 17:35，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-03-04-1735-vk7b50","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"17:35:29","subject":"本公司董事會通過114年第4季財務報告","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-03-04 17:35，「本公司董事會通過114年第4季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-03-04-1732-10eowrl","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:32:48","subject":"公告本公司114年度合併財務報告董事會預計召開日期為115年03月12日","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-03-04 17:32，「公告本公司114年度合併財務報告董事會預計召開日期為115年03月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-03-04-1727-fqsc9p","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"17:27:17","subject":"本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-03-04 17:27，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-04-1725-1tpjosz","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:25:58","subject":"公告本公司法人董事代表人辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-04 17:25，「公告本公司法人董事代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-04-1725-13wdql2","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:25:31","subject":"代子公司CH BIOTECH, LLC公告代表人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-04 17:25，「代子公司CH BIOTECH, LLC公告代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-03-04-1720-1oaynm","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:20:58","subject":"本公司受邀參加台新綜合證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-03-04 17:20，「本公司受邀參加台新綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-03-04-1718-1howjn","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:18:09","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-03-04 17:18，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-04-1711-158ihrk","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"17:11:11","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月12日","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-04 17:11，「公告本公司114年度財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-03-04-1707-1ra24qa","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"17:07:59","subject":"本公司114年度財務報表已提報董事會","clause":"第43款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-03-04 17:07，「本公司114年度財務報表已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-03-04-1707-61u2be","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:07:29","subject":"更正本公司董事會決議召開民國115年股東常會公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-03-04 17:07，「更正本公司董事會決議召開民國115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-03-04-1705-2iz4hx","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:05:46","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-03-04 17:05，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-03-04-1702-5j9yh6","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"17:02:02","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-03-04 17:02，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-03-04-1655-1howjn","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:55:45","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-03-04 16:55，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-04-1648-74a8oc","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:48:56","subject":"公告本公司114年自結合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-04 16:48，「公告本公司114年自結合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-04-1648-12tp1f9","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:48:39","subject":"代重要子公司YSP INTERNATIONAL COMPANY LTD.公告盈餘分派除息基準日訂定","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-04 16:48，「代重要子公司YSP INTERNATIONAL COMPANY LTD.公告盈餘分派除息基準日訂定」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-04-1648-1j840yq","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:48:24","subject":"代重要子公司YSP INTERNATIONAL COMPANY LTD.公告股東會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-04 16:48，「代重要子公司YSP INTERNATIONAL COMPANY LTD.公告股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-04-1648-8yqkkv","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:48:10","subject":"代重要子公司YSP INTERNATIONAL COMPANY LTD.公告董事會決議盈餘分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-04 16:48，「代重要子公司YSP INTERNATIONAL COMPANY LTD.公告董事會決議盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-04-1647-185ltyx","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:47:46","subject":"本公司董事會決議召開2026年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-04 16:47，「本公司董事會決議召開2026年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-03-04-1644-11wjw0o","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:44:39","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-03-04 16:44，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-03-04-1643-1oytiu","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"16:43:41","subject":"公告本公司董事會決議不分配114年度股利","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-03-04 16:43，「公告本公司董事會決議不分配114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-04-1643-78mmw0","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:43:39","subject":"公告本公司114年度財務報告董事會召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-04 16:43，「公告本公司114年度財務報告董事會召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-03-04-1643-vv333v","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:43:03","subject":"本公司董事會決議115年股東常會召開事宜(主旨更正)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-03-04 16:43，「本公司董事會決議115年股東常會召開事宜(主旨更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-04-1639-f7zdi0","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:39:28","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-04 16:39，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-03-04-1638-1nn6mrr","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"16:38:13","subject":"公告114年第4季財務報告董事會預計召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-03-04 16:38，「公告114年第4季財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-04-1638-8gwo37","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"16:38:04","subject":"(更正事實發生日,正確日期為115/02/23)授權夥伴專案進展更新","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-04 16:38，「(更正事實發生日,正確日期為115/02/23)授權夥伴專案進展更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-03-04-1634-5j9yh6","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"16:34:21","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-03-04 16:34，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-03-04-1618-158ihrk","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"16:18:52","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-03-04 16:18，「公告本公司114年度財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-03-04-1618-12a3non","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-03-04","time":"16:18:19","subject":"公告本公司外泌體原料通過日本化妝品原料命名審議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-03-04 16:18，「公告本公司外泌體原料通過日本化妝品原料命名審議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-04-1611-1rivdrz","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"16:11:40","subject":"更正-公告本公司董事會通過114年第4季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-04 16:11，「更正-公告本公司董事會通過114年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-03-04-1557-11b1948","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:57:31","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-03-04 15:57，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-03-04-1555-jz1vzu","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:55:20","subject":"公告本公司115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-03-04 15:55，「公告本公司115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-03-04-1554-bwopfv","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:54:35","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-03-04 15:54，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-03-04-1554-5j9yh6","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:54:07","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-03-04 15:54，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1551-np8q9t","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:51:11","subject":"公告本公司董事會決議召開股東會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:51，「公告本公司董事會決議召開股東會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1550-986is7","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:50:41","subject":"公告本公司董事會通過財務主管、會計主管及公司治理主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:50，「公告本公司董事會通過財務主管、會計主管及公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1549-17up2wc","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:49:37","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:49，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1548-3kb7gv","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:48:54","subject":"本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:48，「本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1548-1wfh00o","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:48:23","subject":"本公司董事會決議不分配114年度員工酬勞及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:48，「本公司董事會決議不分配114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-04-1547-1v7ywe5","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:47:53","subject":"公告本公司114年度合併財務報告董事會召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-04 15:47，「公告本公司114年度合併財務報告董事會召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1547-10e1y9q","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:47:34","subject":"本公司114年度累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:47，「本公司114年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1546-of1da3","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:46:25","subject":"公告本公司董事會通過114年第4季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:46，「公告本公司董事會通過114年第4季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-04-1545-13e51cy","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:45:26","subject":"法人董事指派代表人出席115/03/04董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-04 15:45，「法人董事指派代表人出席115/03/04董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-03-04-1536-f7zdi0","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:36:27","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-03-04 15:36，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-03-04-1535-isqttc","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:35:39","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-03-04 15:35，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-04-1534-biuyf0","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:34:51","subject":"代子公司「中國化學製藥股份有限公司」公告其董事會通過員工酬勞及董監事酬勞分派議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-04 15:34，「代子公司「中國化學製藥股份有限公司」公告其董事會通過員工酬勞及董監事酬勞分派議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-04-1534-3f19ie","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"15:34:28","subject":"代本公司重要子公司中國化學製藥股份有限公司公告其董事會決議發放114年度股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-04 15:34，「代本公司重要子公司中國化學製藥股份有限公司公告其董事會決議發放114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-03-04-1532-5j9yh6","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:32:40","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-03-04 15:32，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2026-03-04-1510-1ctgck9","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:10:18","subject":"本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2026-03-04 15:10，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2026-03-04-1505-1howjn","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"15:05:06","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2026-03-04 15:05，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2026-03-04-1459-bjj82c","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:59:01","subject":"本公司董事會通過114年第4季個別財務報告","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2026-03-04 14:59，「本公司董事會通過114年第4季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-04-1458-fuww0e","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:58:59","subject":"公告本公司114年度財務報告董事會預計召開日期為115年03月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-04 14:58，「公告本公司114年度財務報告董事會預計召開日期為115年03月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-03-04-1456-1nb8hvk","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"14:56:38","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-03-04 14:56，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-03-04-1452-ueirm1","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"14:52:10","subject":"公告本公司董事會決議114年下半年度股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-03-04 14:52，「公告本公司董事會決議114年下半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-03-04-1451-1xlintx","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:51:27","subject":"公告本公司114年度合併財務報告董事會預計召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-03-04 14:51，「公告本公司114年度合併財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-03-04-1449-1howjn","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"14:49:00","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-03-04 14:49，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-03-04-1446-13fdfkx","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"14:46:55","subject":"代本公司重要子公司上海葡萄王企業有限公司公告董事會決議股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-03-04 14:46，「代本公司重要子公司上海葡萄王企業有限公司公告董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-03-04-1446-1fnw3d4","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"14:46:06","subject":"代本公司重要子公司英屬維京群島葡萄王國際投資有限公司公告董事會決議股利分派","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-03-04 14:46，「代本公司重要子公司英屬維京群島葡萄王國際投資有限公司公告董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-04-1443-ko37yn","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:43:10","subject":"代重要子公司高峰藥品材料股份有限公司公告董事會決議通過盈餘轉增資發行新股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-04 14:43，「代重要子公司高峰藥品材料股份有限公司公告董事會決議通過盈餘轉增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-04-1442-1kvbvgc","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:42:45","subject":"代重要子公司高峰藥品材料股份有限公司公告董事會決議股利分派事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-04 14:42，「代重要子公司高峰藥品材料股份有限公司公告董事會決議股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-04-1442-gfep1d","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:42:23","subject":"公告本公司董事會通過114年第4季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-04 14:42，「公告本公司董事會通過114年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-04-1441-sxt04j","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:41:57","subject":"代重要子公司高峰藥品材料股份有限公司公告董事會決議通過115年股東常會之召集事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-04 14:41，「代重要子公司高峰藥品材料股份有限公司公告董事會決議通過115年股東常會之召集事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-03-04-1431-11b1948","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:31:30","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-03-04 14:31，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-03-04-1429-bf8m0l","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:29:42","subject":"公告本公司114年度財務報告董事會預計召開日期為115年03月11日","clause":"第31款","fact_date":"2026-03-03","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-03-04 14:29，「公告本公司114年度財務報告董事會預計召開日期為115年03月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-03-04-1428-11wjw0o","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:28:33","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-03-04 14:28，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-03-04-1424-5j9yh6","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:24:36","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-03-04 14:24，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-03-04-1411-158ihrk","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-03-04","time":"14:11:11","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月12日","clause":"第31款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-03-04 14:11，「公告本公司114年度財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-03-04-0836-1j46v82","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-03-04","time":"08:36:53","subject":"公告本公司現金股利除息基準日","clause":"第14款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-03-04 08:36，「公告本公司現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}